These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19549697)

  • 1. Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis.
    Carrero JJ; Hua X; Stenvinkel P; Qureshi AR; Heimbürger O; Bárány P; Lindholm B; Frostegård J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3454-60. PubMed ID: 19549697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of IgM antibodies against phosphorylcholine predict development of acute myocardial infarction in a population-based cohort from northern Sweden.
    Grönlund H; Hallmans G; Jansson JH; Boman K; Wikström M; de Faire U; Frostegård J
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):382-6. PubMed ID: 19369878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism.
    de Faire U; Su J; Hua X; Frostegård A; Halldin M; Hellenius ML; Wikström M; Dahlbom I; Grönlund H; Frostegård J
    J Autoimmun; 2010 Mar; 34(2):73-9. PubMed ID: 19726160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural antibodies against phosphorylcholine in cardiovascular disease.
    de Faire U; Frostegård J
    Ann N Y Acad Sci; 2009 Sep; 1173():292-300. PubMed ID: 19758165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between novel indices of malnutrition-inflammation complex syndrome and cardiovascular disease in hemodialysis patients.
    Terrier N; Senécal L; Dupuy AM; Jaussent I; Delcourt C; Leray H; Rafaelsen S; Bosc JY; Maurice F; Canaud B; Cristol JP
    Hemodial Int; 2005 Apr; 9(2):159-68. PubMed ID: 16191065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients.
    Kyriazis J; Tzanakis I; Stylianou K; Katsipi I; Moisiadis D; Papadaki A; Mavroeidi V; Kagia S; Karkavitsas N; Daphnis E
    Nephrol Dial Transplant; 2011 Sep; 26(9):2971-7. PubMed ID: 21427069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with polycystic ovary syndrome have lower levels of IgM anti-phosphorylcholine antibodies than healthy women.
    Gingnell M; Dahlbom I; Lindholm A; Hudecova M; Arnadottir R; Hansson T; Sundstrom-Poromaa I
    Gynecol Endocrinol; 2011 Jul; 27(7):486-90. PubMed ID: 20645890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geriatric comorbidities, such as falls, confer an independent mortality risk to elderly dialysis patients.
    Li M; Tomlinson G; Naglie G; Cook WL; Jassal SV
    Nephrol Dial Transplant; 2008 Apr; 23(4):1396-400. PubMed ID: 18057068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
    Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality.
    Suliman ME; Qureshi AR; Carrero JJ; Bárány P; Yilmaz MI; Snaedal-Jonsdottir S; Alvestrand A; Heimbürger O; Lindholm B; Stenvinkel P
    QJM; 2008 May; 101(5):397-405. PubMed ID: 18292098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
    Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
    Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.
    Carrero JJ; Chmielewski M; Axelsson J; Snaedal S; Heimbürger O; Bárány P; Suliman ME; Lindholm B; Stenvinkel P; Qureshi AR
    Clin Nutr; 2008 Aug; 27(4):557-64. PubMed ID: 18538898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
    Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
    Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.